Breezula Phase II Results Positive, Phase III Delayed

Update: Also see Cosmo Pharma’s new page on Breezula. The company took over majority ownership of Cassiopea in December 2021 after being a part-owner for years (see bottom of this post). Update: October 7, 2020 – Cassiopea (Cosmo Pharma) completed enrollment in its Phase II trials for female pattern hair loss. The 6-month study has … Continue reading Breezula Phase II Results Positive, Phase III Delayed

Cassiopea’s Breezula is the Real Deal

Cassiopea has just released excellent news regarding very positive interim Phase 2 results of Breezula. They now also call the product by its new chemical name of Clascoterone. Note that these are interim 6-month results and the trial is still ongoing. Update: Cassiopea stock almost doubled in the past week. This was due to their July 10 … Continue reading Cassiopea’s Breezula is the Real Deal